Review: could Sandostatin lar cause High blood pressure?
Summary: High blood pressure is found among people who take Sandostatin lar, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take medication Synthroid, and have Carcinoid tumour.
We study 9,407 people who have side effects while taking Sandostatin lar from FDA and social media. Among them, 1,514 have High blood pressure. Find out below who they are, when they have High blood pressure and more.
You are not alone: join a support group for people who take Sandostatin lar and have High blood pressure >>>
Sandostatin lar has active ingredients of octreotide acetate. It is often used in acromegaly. (latest outcomes from 9,420 Sandostatin lar users)
High blood pressure
High blood pressure has been reported by people with osteoporosis, depression, multiple sclerosis, pain, rheumatoid arthritis. (latest reports from 329,841 High blood pressure patients)
On Mar, 22, 2015: 9,407 people reported to have side effects when taking Sandostatin lar. Among them, 1,514 people (16.09%) have High Blood Pressure.
Time on Sandostatin lar when people have High blood pressure * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|High blood pressure||23.92%||33.97%||3.35%||9.09%||28.23%||1.44%||0.00% |
Gender of people who have High blood pressure when taking Sandostatin lar * :
|High blood pressure||63.09%||36.91% |
Age of people who have High blood pressure when taking Sandostatin lar * :
|High blood pressure||0.00%||0.00%||0.00%||0.00%||0.11%||18.00%||27.93%||53.95% |
Severity of High blood pressure when taking Sandostatin lar ** :
How people recovered from High blood pressure ** :
Top conditions involved for these people * :
- Carcinoid tumour (744 people, 49.14%)
- Acromegaly (587 people, 38.77%)
- Neuroendocrine tumour (500 people, 33.03%)
- Metastatic carcinoid tumour (357 people, 23.58%)
- Carcinoid tumour of the gastrointestinal tract (288 people, 19.02%)
Top co-used drugs for these people * :
- Synthroid (380 people, 25.10%)
- Sandostatin (355 people, 23.45%)
- Ramipril (261 people, 17.24%)
- Norvasc (204 people, 13.47%)
- Viokase 16 (184 people, 12.15%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of sandostatin lar and high blood pressure on
Do you have High Blood Pressure while taking Sandostatin Lar?
You are not alone! Join a support group on :
- support group for people who take Sandostatin lar and have High Blood Pressure
- support group for people who take Sandostatin lar
- support group for people who have High Blood Pressure
Drugs in real world that are associated with:
Could your condition cause:
Recent Sandostatin lar related drug comparison:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.